MedPage Today December 28, 2024
— GLP-1 drugs remain out of reach for too many Americans
In July 2024, Joseph Zucchi, PA-C, MPAS, wrote about how stigma and misconceptions were creating barriers to GLP-1 obesity medication uptake, on top of systemic barriers like high costs and inadequate insurance coverage. As part of our review of the past year’s biggest events, Zucchi revisited this topic to share his perspective on the proposal from the Centers for Medicare & Medicaid Services (CMS) to expand coverage of these life-changing medications.
Imagine a disease so prevalent it affects more than two-fifths of the adult population and one-fifth of children, yet its most effective treatments remain out of reach for those who need them most. This is the reality of...
Today's Sponsors
Today's Sponsor